Dihydroergotamine monomethanesulfonate en es it fr

Dihydroergotamine monomethanesulfonate Brand names, Dihydroergotamine monomethanesulfonate Analogs

Dihydroergotamine monomethanesulfonate Brand Names Mixture

  • No information avaliable

Dihydroergotamine monomethanesulfonate Chemical_Formula

C33H37N5O5

Dihydroergotamine monomethanesulfonate RX_link

http://www.rxlist.com/cgi/generic2/dihyergmes.htm

Dihydroergotamine monomethanesulfonate fda sheet

Dihydroergotamine_monomethanesulfonate FDA

Dihydroergotamine monomethanesulfonate msds (material safety sheet)

Dihydroergotamine_monomethanesulfonate MSDS

Dihydroergotamine monomethanesulfonate Synthesis Reference

No information avaliable

Dihydroergotamine monomethanesulfonate Molecular Weight

583.678 g/mol

Dihydroergotamine monomethanesulfonate Melting Point

No information avaliable

Dihydroergotamine monomethanesulfonate H2O Solubility

No information avaliable

Dihydroergotamine monomethanesulfonate State

Solid

Dihydroergotamine monomethanesulfonate LogP

No information avaliable

Dihydroergotamine monomethanesulfonate Dosage Forms

Liquid

Dihydroergotamine monomethanesulfonate Indication

For the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes.

Dihydroergotamine monomethanesulfonate Pharmacology

Dihydroergotamine is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes. Dihydroergotamine binds with high affinity to 5-HT1Da and 5-HT1Db receptors. It also binds with high affinity to serotonin 5-HT1A, 5-HT2A, and 5-HT2C receptors, noradrenaline a2A, a2B and a receptors, and dopamine D2L and D3 receptors. The therapeutic activity of Dihydroergotamine in migraine is generally attributed to the agonist effect at 5-HT1D receptors.

Dihydroergotamine monomethanesulfonate Absorption

Interpatient variable and may be dependent on the administration technique

Dihydroergotamine monomethanesulfonate side effects and Toxicity

Side effects include abdominal pain, abnormal speech, coma, confusion, convulsions, hallucinations, increase and/or decrease in blood pressure, nausea, numbness, tingling, pain, and a bluish color of your fingersand toes, slowed breathing, vomiting

Dihydroergotamine monomethanesulfonate Patient Information

PATIENT INFORMATIOn

Follow the link below to get detailed information before taking D.H.E. 45 (dihydroergotamine mesylate) Injection.

http://www.rxlist.com/cgi/generic2/dihyergmes_pi.htm

Dihydroergotamine monomethanesulfonate Organisms Affected

Humans and other mammals